Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Elaprase (Indursulfase) Injection
Company: Shire Human Genetic Therapies, Inc.
Application No.: 125151
Approval Date: 07/24/2006


Date created: September 26, 2006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.